INS and type 2 diabetes mellitus: Metabolic syndrome (MetS) is a multi-component disorder characterized by abdominal obesity, dyslipidaemia, hypertension and impaired insulin sensitivity, and it is associated with an increased risk of type 2 diabetes (T2DM) and cardiovascular diseases (CVD) [1, 2].